Dear Colleague:

Welcome to the 16th Annual Scientific Meeting of the Society for Biological Therapy. I know that we all are excited to be holding this year’s conference on the campus of our National Institutes of Health in Bethesda, Maryland.

This year’s conference organizers, Jon Wigginton, MD and Steven Libutti, MD of the National Cancer Institute, Robert Zimmerman, SD of Bayer Corporation, and Michael Atkins, MD of Beth Israel Deaconess Medical Center, have compiled an outstanding program that will feature some of the most interesting translational research in cancer biotherapy. The program features keynote addresses by Steven A. Rosenberg, MD, PhD of the National Cancer Institute, who has devoted his career to the pursuit of the immunotherapy of cancer using cytokines, adoptive cellular therapy, vaccines, and gene therapy and William A. Haseltine, PhD of Human Genome Sciences, who, after years of research in retrovirology at Dana Farber Cancer Institute, is now heavily involved in the commercial development of new drug products discovered through genomics, the systematic study of the human genome.

Specific scientific sessions will address the timely topics of Cytokines, Angiogenesis, Vaccines & Dendritic Cells, Antibody Therapy and Gene Therapy. We will also hear presentations on Pharmacogenomics & Product Discovery and New Agents in Development. The Presidential Session will feature oral presentations of the best abstracts submitted by junior investigators, one of which will be selected for a prestigious money award. In addition to these oral programs, there will be a poster session in the middle of each day.

Over the next several days, you will have ample opportunity to mingle informally with your colleagues. In addition to the poster sessions, there will be a Cocktail Reception on Friday evening and the Presidential Reception on Saturday evening. Those of you who are members of the society are cordially invited to assemble for the annual member luncheon and business meeting on Saturday.

We hope you find the meeting to be of the highest educational value, and, if you are not already a member, we hope you will become a member of the Society for Biological Therapy.